Skip to content
Does AstraZeneca (AZN) still have a fighting chance in the COVID-19 vaccine race? Earlier this month, the healthcare giant paused the Phase 3 study of AZD1222, its experimental COVID-19 vaccine developed as part of a collaboration with the University of Oxford, after one of the participants developed an unexplained illness, a potential adverse effect. This effect was later described as transverse myelitis, a demyelinating condition.Even though the UK study has resumed, the U.S. study remains on hold. Against this backdrop, AZN released the protocol for the trial, demonstrating the “rigorous” criteria of the interim analysis, in SVB Leerink analyst Andrew Berens’ opinion.AZD1222's criteria for success is based on the FDA's Guidance for Industry regarding COVID-19 vaccine development, which asserts that an observed vaccine efficacy (VE) point estimate should be at least 50%, and that the lower bound of the confidence interval (CI) should be over 30%.AZN’s first interim analysis (IA) will...
Keeping your fleet on the road is more than just ensuring your trucks are ready to roll; trailers need love, too. ...
After a tough week, stocks put together a decent rally on Friday. Let's look at a few top stock trades going into next week, the last week of September. Top Stock Trades for Monday No. 1: Rite Aid (RAD) Click to EnlargeSource: Chart courtesy of StockCharts.comRite Aid (NYSE:RAD) shares are under significant pressure for the second straight day. The stock ended the day down about 9% on Friday, after falling almost 18% on Thursday on earnings.The stock made a decisive close below the September low on Thursday and the selling is continuing on Friday. Now, there are two levels to keep an eye on.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThat puts the March low in play at $9.24, followed by the December gap-fill at $8.36. * 7 Hot Stocks to Buy on Robinhood Now On the upside, investors must see if RAD stock can reclaim $11. If so,...
If you want to know the simple reason for buying shares of online pet products retailer Chewy (NYSE:CHWY), it's this: Americans love their pets. And that's good news for Chewy stock.Source: Chie Inoue / Shutterstock.com It's not just that, though, as this sentiment also carries a significant dollar amount. According to the American Pet Products Association, we collectively spent $95.7 billion for our furry friends. Furthermore, this is estimated to move up to $99 billion by end of 2020. Therefore, Chewy stock is levered to one of the most relevant industries.Just as importantly, the household penetration rate for pet ownership in this country has steadily increased. For instance, back in 1988, the penetration rate was 56%. Fast forward 20 years later and this metric increased to 62%. Last year, according to the same pet association, 67% of households owned pets. So for stakeholders of Chewy stock, the novel coronavirus may actually...
House Democrats are putting together another coronavirus stimulus plan, which would cost about $2.4 trillion. The chamber could vote on the legislation, which would include unemployment benefits, direct payments, small business loans and airline aid, as soon as next week. Yahoo Finance’s Jessica Smith joins The Final Round panel to discuss.
...
A proportional tax, also known as a flat tax, is a type of tax system that levies the same tax rate on everyone, no matter their income level. This system is in contrast to the progressive or marginal tax system … Continue reading ->The post What Is a Proportional Tax? appeared first on SmartAsset Blog....
